An educational #Thread on how 1 can identify "Freakout"(Fake Breakout) explained with practical e.g's so that every1 can understand.

Identifying Breakout is not a big challenge but exiting it at the right time if it "fails" with minor loss is imp. which 90% people don't do.

1/n

1st lets learn how to judge that the Breakout is not sustaining & time to exit the trade has come for once.

With digital content available identifying #Stocks breaking resistance is not a big task but exiting these trades timely if they go against us is the most imp. thing.

2/n
Let's understand the abv with recent e.g of USDINR. It gave a breakout abv 75.6 after 8 months. Though we saw a mild upmove after that but it drastically failed& cmp is 74.5.

Now if some1 bought on breakout then usually most will hold it till now or exit at cmp in distress.

3/n
If any of the following 2 criteria's match then 1 should exit the trade.

* Stock makes a LowerLow, LowerHigh consecutively for 2 days.
* It breaks the low of breakout candle & sustains for 1 day.

USDINR made a LL,LH for 2 days on 17th,20th Dec so exit was at 75.73 on 20th.

4/n
Similar e.g is Bharti which gave a ATH, consolidation breakout on 23rd nov abv 745. The Breakout couldn't sustain & cmp is 684.

Ideal exit was on 29th Nov at 739 when it broke the breakout candle low of 733 & sustained below it on 29th. So it fulfilled 2nd criteria of exit.

5/n
The same theory is valid even for breakdowns which can be seen in Cipla where it broke 8 months tight range on 17th Dec & on 18th broke the breakdown high.

Hence it met the 2nd criteria of sustaining abv Breakdown high & immediately 1 should have exited shorts, built longs.

6/n
The most recent e.g 1 can see is Dow jones which gave a breakout on 29th. However on friday it has made a LH, LL formation which isn't good & if it again makes it on Mon then 1 should exit longs taken on the basis of the breakout on thurs.

So let's watch next week closely.

7/n
"No Capital No Capital Markets" - The above thread is dedicated to same.

1 can always renter such trades but exiting them timely is very imp. & my personal experience says that deciding exiting trades criteria, time is where 90% fail.

THE END.

Feedbacks, views are appreciated.

More from Screeners

TradingView isn't just charts

It's much more powerful than you think

9 things TradingView can do, you'll wish you knew yesterday: 🧵

Collaborated with @niki_poojary

1/ Free Multi Timeframe Analysis

Step 1. Download Vivaldi Browser

Step 2. Login to trading view

Step 3. Open bank nifty chart in 4 separate windows

Step 4. Click on the first tab and shift + click by mouse on the last tab.

Step 5. Select "Tile all 4 tabs"


What happens is you get 4 charts joint on one screen.

Refer to the attached picture.

The best part about this is this is absolutely free to do.

Also, do note:

I do not have the paid version of trading view.


2/ Free Multiple Watchlists

Go through this informative thread where @sarosijghosh teaches you how to create multiple free watchlists in the free


3/ Free Segregation into different headers/sectors

You can create multiple sections sector-wise for free.

1. Long tap on any index/stock and click on "Add section above."
2. Secgregate the stocks/indices based on where they belong.

Kinda like how I did in the picture below.

You May Also Like

@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)

@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice


@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2


@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj


@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o